Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.
G1 Therapeutics Says Receives Fast Track Designation From FDA For COSELA In Combination With Chemotherapy For Treatment Of Locally Advanced Or Metastatic Triple Negative Breast Cancer
G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to COSELA™ (trilaciclib) investigation
G1 Therapeutics Starts Mid-Stage Bladder Cancer Trial With Cosela
G1 Therapeutics Inc (NASDAQ:GTHX) has initiated the PRESERVE 3 Phase 2 study evaluating Cosela (trilaciclib) in patients with untreated, locally advanced,…
G1 Therapeutics Initiates PRESERVE 3, A Randomized Phase 2 Study Of COSELA In Bladder Cancer
G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced that the Company has initiated PRESERVE 3, a Phase 2, randomized, open-label study of COSELA™ (trilaciclib) administered
G1 Therapeutics Presents Phase 1 Data At ASCO Describing ‘Favorable Safety Profile and Evidence Of Antitumor Activity Of Rintodestrant Combined With Palbociclib In Patients With ER+/HER2- Advanced Breast Cancer’
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today presented results from its Phase 1 study of its oral selective estrogen receptor degrader (SERD), rintodestrant,
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.
Pharma/Biotech Companies Highlight Upcoming Presentations At American Society Of Clinical Oncology Jun. 4-8, 2021
Cullinan Oncology (CGEM) - https://www.globenewswire.com/news-release/2021/05/19/2232874/0/en/Cullinan-Oncology-to-Provide-CLN-081-Clinical-Update-at-ASCO-2021.html
BeiGene (BGNE)
14 Stocks Moving In Wednesday’s After-Hours Session
Gainers
Moderna (NASDAQ: MRNA) shares are trading higher after the company reported initial booster data against SARS-CoV-2 variants of concern.